SCHEMBL401549

SCHEMBL401549

CCN(C)CCCCN(C)CC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.45
KDM5A P29375 1/20 0.45
KDM4C Q9H3R0 1/20 0.45
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
DNM1 Q05193 3/20 0.40
S1PR2 O95136 1/20 0.36
S1PR1 P21453 1/20 0.36
S1PR3 Q99500 1/20 0.36
S1PR5 Q9H228 1/20 0.36
GGPS1 O95749 3/20 0.33
SIGMAR1 Q99720 1/20 0.33
CA12 O43570 1/20 0.33
CA2 P00918 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15958687 0.96 CHRM2 (0.50) CHRM2KDM5AKDM4CALDH1A1TSHR
SCHEMBL13856002 0.96 CHRM2 (0.50) CHRM2KDM5AKDM4CALDH1A1TSHR
SCHEMBL5715282 0.92 KDM5A (0.40) CHRM2KDM5AKDM4CALDH1A1TSHR
SCHEMBL13510911 0.90 ALDH1A1 (0.59) CHRM2KDM5AKDM4CALDH1A1TSHR
SCHEMBL2872138 0.90
SCHEMBL24111212 0.89 CHRM2 (0.43) CHRM2KDM5AKDM4CALDH1A1TSHR
SCHEMBL15966132 0.87 DNM1 (0.60) CHRM2KDM5AKDM4CALDH1A1TSHR
SCHEMBL2325537 0.87 DNM1 (0.60) CHRM2KDM5AKDM4CALDH1A1TSHR
SCHEMBL5450695 0.87 DNM1 (0.60) CHRM2KDM5AKDM4CALDH1A1TSHR
Hydrochloric Acid SCHEMBL22771569 0.87 DNM1 (0.57) CHRM2KDM5AKDM4CTSHRDNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4516769-A1 METHOD FOR PRODUCING ALCOHOL Resonac Corporation (JP) 2025-03-05 EP disclosed
US-20250059117-A1 METHOD FOR PRODUCING ALCOHOL RESONAC CORPORATION (JP) 2025-02-20 US disclosed
CN-118660869-A Process for producing alcohol 株式会社力森诺科 2024-09-17 CN disclosed
US-9574084-B2 Hole transport composition E I DU PONT DE NEMOURS AND COMPANY (US) 2017-02-21 US disclosed
US-20160329497-A1 HOLE TRANSPORT MATERIALS LG CHEM, LTD. (KR) 2016-11-10 US disclosed
US-20160308141-A1 SOLVENT-RESISTANT HOLE TRANSPORT LAYERS LG CHEM, LTD. (KR) 2016-10-20 US disclosed
US-9306185-B2 Process and materials for making contained layers and devices made with same E I DU PONT DE NEMOURS AND COMPANY (US) 2016-04-05 US disclosed
US-9159927-B2 Electroactive materials E I DU PONT DE NEMOURS AND COMPANY (US) 2015-10-13 US disclosed
US-20150060798-A1 MONOMERS, POLYMERS AND ORGANIC ELECTRONIC DEVICES SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2015-03-05 US disclosed
US-8889269-B2 Electroactive materials E I DU PONT DE NEMOURS AND COMPANY (US) 2014-11-18 US disclosed
US-20140034941-A1 PROCESS AND MATERIALS FOR MAKING CONTAINED LAYERS AND DEVICES MADE WITH SAME E I DU PONT DE NEMOURS AND COMPANY (US) 2014-02-06 US disclosed
US-20130193423-A1 ELECTROACTIVE MATERIALS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-08-01 US disclosed
US-20130150536-A1 HOLE TRANSPORT COMPOSITION E I DU PONT DE NEMOURS AND COMPANY (US) 2013-06-13 US disclosed
US-8343381-B1 Hole transport composition E I DU PONT DE NEMOURS AND COMPANY (US) 2013-01-01 US disclosed
US-20120187382-A1 ELECTRONIC DEVICES HAVING LONG LIFETIME E.I. DUPONT DE NEMOURS AND COMPANY (US) 2012-07-26 US disclosed
US-20120065432-A1 ELECTROACTIVE MATERIALS E.I DU PONT DE NEMOURS AND COMPANY (US) 2012-03-15 US disclosed
US-20120013245-A1 ELECTROACTIVE MATERIALS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-01-19 US disclosed
US-8063399-B2 Electroactive materials E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-11-22 US disclosed
US-20110095269-A1 ELECTROACTIVE MATERIALS E. I. DU PONT DE NEMOURS AND COMPANY 2011-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120013245-A1 ELECTROACTIVE MATERIALS NAT1, ADRA1D, ADRA1B CHRM2 26/4885KDM5A 4336/4885KDM4C 3576/4885
US-20120065432-A1 ELECTROACTIVE MATERIALS NAT1, ADRA1D, ADRA1B CHRM2 26/4885KDM5A 4336/4885KDM4C 3576/4885
US-20160308141-A1 SOLVENT-RESISTANT HOLE TRANSPORT LAYERS SLC11A2, H1-10, H1-0 CHRM2 154/4885KDM5A 2973/4885KDM4C 1641/4885
US-20250059117-A1 METHOD FOR PRODUCING ALCOHOL ADH1C, ADH1A, ADH5 CHRM2 763/4885KDM5A 2114/4885KDM4C 1047/4885
US-20110095269-A1 ELECTROACTIVE MATERIALS NAT1, ADRA1D, ADRA1B CHRM2 26/4885KDM5A 4336/4885KDM4C 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.